• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN PROTEGE RX CAROTID STENT SYSTEM; STENT, CAROTID Back to Search Results
Catalog Number SEPX-8-6-30-135
Device Problems Difficult to Remove (1528); Activation, Positioning or Separation Problem (2906)
Patient Problems Vasoconstriction (2126); Patient Problem/Medical Problem (2688)
Event Date 10/04/2017
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
The physician was attempting to use a protege rx stent with spider embolic protection to treat a 10 mm plaque lesion in the proximal common carotid artery.The artery was 6-7 mm in diameter and had moderate tortuosity.The lesion was not calcified.The devices were prepped and inspected as per the ifu with no issues identified.The lesion was not pre-dilated.The device did not pass through a previously deployed stent and the physician did not encounter resistance during advancement, no excessive force was used.It was reported that the protege rx stent opened partially and could not be deployed.The physician attempted to retrieve the spider and stent through the guidewire.During retrieval, the spider device was damaged and the vessel went into spasm.The patient was treated with vasodilators and the case was postponed.
 
Manufacturer Narrative
Device evaluation summary: the protégé rx device was returned for evaluation.The protégé rx stent delivery system was received without a stent.Within its shelf carton, the device was in its transportation tray.No cines or procedure notes were returned for evaluation.The protégé rx was removed from the tray and noted the tuohy-borst valve was loose and could be tightened.The deployment paddle was approximately 95mm from the tuohy borst valve cap.The protégé rx stent delivery system was received without a stent.The retainer was present with no abnormalities observed.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROTEGE RX CAROTID STENT SYSTEM
Type of Device
STENT, CAROTID
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key6999712
MDR Text Key90998093
Report Number2183870-2017-00477
Device Sequence Number1
Product Code NIM
Combination Product (y/n)N
Reporter Country CodeIN
PMA/PMN Number
P060001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/22/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/03/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/04/2018
Device Catalogue NumberSEPX-8-6-30-135
Device Lot NumberA223206
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/12/2018
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/29/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/05/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-